Novo Nordisk (Denmark) Analysis
| NOVO-B Stock | DKK 757.30 9.70 1.30% |
Novo Nordisk AS is overvalued with Real Value of 660.03 and Hype Value of 757.3. The main objective of Novo Nordisk stock analysis is to determine its intrinsic value, which is an estimate of what Novo Nordisk AS is worth, separate from its market price. There are two main types of Novo Nordisk's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Novo Nordisk's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Novo Nordisk's stock to identify patterns and trends that may indicate its future price movements.
The Novo Nordisk stock is traded in Denmark on Copenhagen Exchange, with the market opening at 09:00:00 and closing at 17:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Denmark. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Novo Nordisk's ongoing operational relationships across important fundamental and technical indicators.
Novo |
Novo Stock Analysis Notes
About 39.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.0. Novo Nordisk AS recorded earning per share (EPS) of 24.44. The entity last dividend was issued on the 12th of August 2022. The firm had 1:2 split on the 13th of September 2023. Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Novo Nordisk operates under Pharmaceuticals And Biosciences classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 45971 people. To find out more about Novo Nordisk AS contact Lars Jorgensen at 45 44 44 88 88 or learn more at https://www.novonordisk.com.Novo Nordisk AS Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Novo Nordisk's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Novo Nordisk AS or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Novo Nordisk AS generated a negative expected return over the last 90 days |
Novo Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.24 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novo Nordisk's market, we take the total number of its shares issued and multiply it by Novo Nordisk's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Novo Profitablity
Novo Nordisk's profitability indicators refer to fundamental financial ratios that showcase Novo Nordisk's ability to generate income relative to its revenue or operating costs. If, let's say, Novo Nordisk is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Novo Nordisk's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Novo Nordisk's profitability requires more research than a typical breakdown of Novo Nordisk's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.43 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.43. Technical Drivers
As of the 1st of December, Novo Nordisk secures the Risk Adjusted Performance of (0.11), standard deviation of 1.94, and Mean Deviation of 1.49. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novo Nordisk AS, as well as the relationship between them.Novo Nordisk AS Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Novo Nordisk middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Novo Nordisk AS. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Novo Nordisk Outstanding Bonds
Novo Nordisk issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Novo Nordisk AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Novo bonds can be classified according to their maturity, which is the date when Novo Nordisk AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Novo Nordisk Predictive Daily Indicators
Novo Nordisk intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Novo Nordisk stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Novo Nordisk Forecast Models
Novo Nordisk's time-series forecasting models are one of many Novo Nordisk's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novo Nordisk's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Novo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Novo Nordisk prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novo Nordisk. By using and applying Novo Stock analysis, traders can create a robust methodology for identifying Novo entry and exit points for their positions.
Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Novo Nordisk operates under Pharmaceuticals And Biosciences classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 45971 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Novo Nordisk to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |